Already facilitating 2 million medical appointments between medical professionals and patients, health tech company 1st Group (ASX: 1ST) is set…
Under new management, medtech company Respiri (ASX: RSH) is poised to enter the lucrative SaaS revenue market by leveraging their…
Biotech company Genetic Signatures (ASX: GSS) is poised to play a major role in flattening the curve of coronavirus cases…
As the world battles the coronavirus pandemic, G Medical (ASX: GMV) has secured authorisation from the Food and Drug Administration…
As an industry which had already been fighting for survival before the coronavirus pandemic, the stark reality is that the…
Prior to COVID-19 bringing attention to the value of telehealth, HeraMED (ASX: HMD) has been building digital infrastructure to revolutionise…